IntelliPharmaCeutics To Present At Two Upcoming Investor Conferences
3/5/2014 9:05:28 AM
TORONTO, March 4, 2014 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I), a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs, announced today that the Company is scheduled to present at the following two upcoming conferences.
Help employers find you! Check out all the jobs and post your resume.
comments powered by